FF
MGNX icon

FourThought Financial’s MacroGenics MGNX Stock Holding History

FourThought Financial’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$0 Hold
36
– – ﹤0.01% 1537
2022
Q2 		$0 Hold
36
– – ﹤0.01% 1518
2022
Q1 		$0 Hold
36
– – ﹤0.01% 1527
2021
Q4 		$1K Hold
36
– – ﹤0.01% 1442
2021
Q3 		$1K Hold
36
– – ﹤0.01% 1468
2021
Q2 		$1K Hold
36
– – ﹤0.01% 1457
2021
Q1 		$1K Hold
36
– – ﹤0.01% 1424
2020
Q4 		$1K Buy
+36
New +$829 ﹤0.01% 1411

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FourThought Financial's MGNX Position: Q3 2022 in Review

FourThought Financial held its MacroGenics (MGNX) position steady in Q3 2022 at 36 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1537.

FourThought Financial first reported a position in MGNX in Q4 2020 and has held it in 8 quarters since. The position peaked at $1K in Q4 2021. 135 funds tracked by Wall St. Rank hold MGNX as of Q3 2022.

  • FourThought Financial held 36 shares of MacroGenics worth $0 as of Q3 2022.
  • FourThought Financial left its MacroGenics share count unchanged in Q3 2022.
  • MacroGenics made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #1537 holding.
  • FourThought Financial first reported a position in MacroGenics in Q4 2020 and has held it in 8 quarters since.
  • FourThought Financial's MacroGenics position peaked at $1K in Q4 2021.
  • 135 funds tracked by Wall St. Rank held MacroGenics as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.